The occlusal wear of ceramic fixed dental prostheses: 3-Year results in a randomized controlled clinical trial with split-mouth design.

Ceramic fixed dental prosthesis Clinical trial Glass–ceramic Lithium disilicate Occlusal wear Veneered zirconia

Journal

Journal of dentistry
ISSN: 1879-176X
Titre abrégé: J Dent
Pays: England
ID NLM: 0354422

Informations de publication

Date de publication:
12 2020
Historique:
received: 28 07 2020
revised: 23 09 2020
accepted: 10 10 2020
pubmed: 17 10 2020
medline: 11 3 2021
entrez: 16 10 2020
Statut: ppublish

Résumé

This study's hypothesis was to evaluate differences of the occlusal wear rate for monolithically fabricated lithium disilicate and hand-veneered zirconia crowns in-vivo. Furthermore, a comparison of the materials' clinical performance according to CDA criteria was investigated. A total number of 15 patients in the need of full-coverage ceramic fixed dental prosthesis on molars were treated with two crowns each (n = 30), randomly assigned on the contralateral sides made of monolithic IPS e.max CAD (n = 15) and IPS e.max Ceram hand-veneered zirconia (n = 15). Clinical examination was conducted, silicone impressions were taken and plaster models fabricated at the day of crown insertion (baseline) and after 1, 2 and 3 years. The abrasion rate was digitally investigated: after model digitization with the industrial scanner Atos II, each follow-up model was superimposed with the baseline model. The wear was evaluated as the difference between two scans in terms of maximum vertical loss [mm], average decrease [mm] and volume loss [mm³]. For statistical analysis, the Mann-Whitney U test was performed and significance was set to less than 0.05. IPS e.max CAD crowns showed a volume loss of -0.68 mm³ after three years, while IPS e.max Ceram hand-veneered zirconia crowns showed a volumetric wear of -0.75 mm³ at the same point of time. However, no significant differences were found between both materials regarding the 3 evaluated wear parameters. The survival rate for both materials was 100 % and the clinical performance outcome was good to excellent. The two investigated materials for ceramic fixed dental prostheses showed similar wear rates and clinical performance over an in-vivo use of 3 years. Ceramic restorations are subject to occlusal wear over time due to the natural masticatory process. Both monolithic lithium disilicate and glass-ceramic veneered zirconia copings showed clinically satisfactory results over 3 years in-situ. In terms of abrasion, they are equally well suited for clinical use.

Identifiants

pubmed: 33065218
pii: S0300-5712(20)30247-5
doi: 10.1016/j.jdent.2020.103500
pii:
doi:

Substances chimiques

Dental Porcelain 12001-21-7
Zirconium C6V6S92N3C

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103500

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Anna Seidel (A)

Department of Prosthodontics, University Hospital Erlangen of Friedrich-Alexander University Erlangen-Nürnberg (FAU), Glueckstrasse 11, 91054, Erlangen, Germany. Electronic address: anna.seidel@uk-erlangen.de.

Renan Belli (R)

Laboratory of Dental Biomaterials, Department of Restorative Dentistry, University Hospital Erlangen of Friedrich-Alexander University Erlangen Nürnberg (FAU), Glueckstrasse 11, 91054, Erlangen, Germany.

Nathalie Breidebach (N)

Department of Prosthodontics, University Hospital Erlangen of Friedrich-Alexander University Erlangen-Nürnberg (FAU), Glueckstrasse 11, 91054, Erlangen, Germany.

Manfred Wichmann (M)

Department of Prosthodontics, University Hospital Erlangen of Friedrich-Alexander University Erlangen-Nürnberg (FAU), Glueckstrasse 11, 91054, Erlangen, Germany.

Ragai Edward Matta (RE)

Department of Prosthodontics, University Hospital Erlangen of Friedrich-Alexander University Erlangen-Nürnberg (FAU), Glueckstrasse 11, 91054, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH